To further confirm whether METTL5 acts as an oncogene in MM, we silenced METTL5 expression in RPMI-8226 and U266 cells using two independent short hairpin RNAs (shRNAs) (Fig. 3A, B, Supplementary Fig. 3A, B). This evidence concerns the gene METTL5 and Miyoshi myopathy.